tiprankstipranks
AN2 Therapeutics reports Q4 EPS (57c), consensus (75c)
PremiumThe FlyAN2 Therapeutics reports Q4 EPS (57c), consensus (75c)
4M ago
ANTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ANTX Earnings this Week: How Will it Perform?
4M ago
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
5M ago
AN2 Therapeutics Inc trading halted, volatility trading pause
PremiumThe FlyAN2 Therapeutics Inc trading halted, volatility trading pause
5M ago
AN2 Therapeutics downgraded on efficacy questions at Leerink
PremiumThe Fly
AN2 Therapeutics downgraded on efficacy questions at Leerink
5M ago
AN2 Therapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
AN2 Therapeutics downgraded to Market Perform from Outperform at Leerink
5M ago
AN2 Therapeutics Reviews Epetraborole Phase 3 Trial Enrollment
PremiumCompany AnnouncementsAN2 Therapeutics Reviews Epetraborole Phase 3 Trial Enrollment
5M ago
AN2 Therapeutics Reviews Phase 2 Data, Pauses Phase 3 Trial Enrollment
PremiumCompany Announcements
AN2 Therapeutics Reviews Phase 2 Data, Pauses Phase 3 Trial Enrollment
5M ago
AN2 Therapeutics pausing enrollment in Phase 2 trial of epetraborole
PremiumThe Fly
AN2 Therapeutics pausing enrollment in Phase 2 trial of epetraborole
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100